RPL554: Phase I/IIa data

A double-blind, Dutch Phase I/IIa trial in 18 healthy volunteers in and 16 patients with asthma showed that single ascending-doses of 0.003-0.018 mg/kg RPL554 were well tolerated with no significant c...